Not Yet Recruiting
First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
NCT07505043
- Conditions
- Dyslipidemias, Healthy Subjects, Hyperlipidemia, Hypertriglyceridemia, +5 more
- Locations
-
- The First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China